Silexion Therapeutics Corp · NASDAQ:SLXN
Hadar Ilan received 10,000 Silexion Therapeutics Corp shares as an award (Form 4)
Traded Jun 4, 2026 · Filed Jun 8, 2026
On Jun 4, 2026, Hadar Ilan (Director, Chairman and CEO) received 10,000 Silexion Therapeutics Corp shares as an award, leaving 16,547 shares. Filed Jun 8, 2026 (Form 4).
- Awarded
- 10,000 shares
- Holding after
- 16,547 shares
- Trading plan
- No
- Role
- Director, Chairman and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Ordinary Shares | Award | 10,000 | 16,547 | Direct |
Source
Related
- Silexion Therapeutics Corp
- Hadar Ilan
- Silexion Therapeutics Corp shareholders
- Schedule 13D/A · Moringa Sponsor, LP · Sep 28, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Aug 19, 2026
- Schedule 13G · Mitchell P. Kopin · Aug 18, 2026
- Schedule 13D/A · Moringa Sponsor, LP · Jun 23, 2026
- Form 4 · Shirvan Mitchell · Jun 8, 2026